Author Wirths, Oliver
-
2024 | Journal Article
Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer’s disease
Morgado, B.; Klafki, H.-W.; Bauer, C.; Waniek, K.; Esselmann, H.; Wirths, O. & Hansen, N. et al. (2024)
European Archives of Psychiatry and Clinical Neuroscience,. DOI: https://doi.org/10.1007/s00406-023-01751-2
Details DOI
-
2023 | Journal Article |
A novel interface between the N-terminal and coiled-coil domain of STAT1 functions in an auto-inhibitory manner
Remling, L.; Gregus, A.; Wirths, O.; Meyer, T. & Staab, J. F. (2023)
Cell Communication and Signaling, 21(1) art. 170. DOI: https://doi.org/10.1186/s12964-023-01124-1
Details DOI
-
2023 | Journal Article |
A Combination of Caffeine Supplementation and Enriched Environment in an Alzheimer’s Disease Mouse Model
Stazi, M.; Zampar, S.; Klafki, H.-W.; Meyer, T. & Wirths, O. (2023)
International Journal of Molecular Sciences, 24(3). DOI: https://doi.org/10.3390/ijms24032155
Details DOI
-
2023 | Journal Article
Matrix Development for the Detection of Phosphorylated Amyloid-β Peptides by MALDI-TOF-MS
Liepold, T.; Klafki, H.-W.; Kumar, S.; Walter, J.; Wirths, O.; Wiltfang, J. & Jahn, O. (2023)
Journal of the American Society for Mass Spectrometry, art. jasms.2c00270. DOI: https://doi.org/10.1021/jasms.2c00270
Details DOI
-
2023 | Journal Article |
Brain Region-Specific Differences in Amyloid-β Plaque Composition in 5XFAD Mice
Bader, A. S.; Gnädig, M.-U.; Fricke, M.; Büschgens, L.; Berger, L. J.; Weggen, S. & Klafki, H.-W. et al. (2023)
Life, 13(4) pp. 1053. DOI: https://doi.org/10.3390/life13041053
Details DOI
-
2023 | Journal Article
Blood plasma biomarkers for Alzheimer’s disease: Aβ1–42/1–40 vs. AβX–42/X–40
Klafki, H.-W.; Wirths, O.; Jahn, O.; Morgado, B.; Esselmann, H. & Wiltfang, J. (2023)
Clinical Chemistry and Laboratory Medicine,. DOI: https://doi.org/10.1515/cclm-2023-0990
Details DOI
-
2023 | Preprint
Oligodendrocytes and neurons contribute to amyloid-β deposition in Alzheimer’s disease
Sasmita, A. O.; Depp, C.; Nazarenko, T.; Sun, T.; Siems, S. B.; Yu, X.& Boehler, C. et al. (2023). DOI: https://doi.org/10.1101/2023.12.11.570514
Details DOI
-
2022 | Journal Article |
Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?
Klafki, H.-W.; Morgado, B.; Wirths, O.; Jahn, O.; Bauer, C.; Esselmann, H. & Schuchhardt, J. et al. (2022)
Fluids and Barriers of the CNS, 19(1) art. 96. DOI: https://doi.org/10.1186/s12987-022-00390-4
Details DOI
-
2022 | Journal Article | Research Paper
An inhibitory effect on the nuclear accumulation of phospho-STAT1 by its unphosphorylated form
Menon, P. R.; Staab, J.; Gregus, A.; Wirths, O. & Meyer, T. (2022)
Cell Communication and Signaling, 20(1) art. 42. DOI: https://doi.org/10.1186/s12964-022-00841-3
Details DOI
-
2022 | Journal Article |
Combined long-term enriched environment and caffeine supplementation improve memory function in C57Bl6 mice
Stazi, M.; Zampar, S.; Nadolny, M.; Büschgens, L.; Meyer, T. & Wirths, O. (2022)
European Archives of Psychiatry and Clinical Neuroscience,. DOI: https://doi.org/10.1007/s00406-022-01431-7
Details DOI
-
2021 | Journal Article |
Long-term caffeine treatment of Alzheimer mouse models ameliorates behavioural deficits and neuron loss and promotes cellular and molecular markers of neurogenesis
Stazi, M.; Lehmann, S.; Sakib, M. S.; Pena-Centeno, T.; Büschgens, L.; Fischer, A. & Weggen, S. et al. (2021)
Cellular and Molecular Life Sciences, 79(1) art. 55. DOI: https://doi.org/10.1007/s00018-021-04062-8
Details DOI
-
2021 | Journal Article | Research Paper |
Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease
Aichholzer, F.; Klafki, H.-W.; Ogorek, I.; Vogelgsang, J.; Wiltfang, J.; Scherbaum, N. & Weggen, S. et al. (2021)
Alzheimer's Research & Therapy, 13(1) art. 94. DOI: https://doi.org/10.1186/s13195-021-00828-1
Details DOI
-
2016 | Journal Article
Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease
Weissmann, R.; Huettenrauch, M.; Kacprowski, T.; Bouter, Y.; Pradier, L.; Bayer, T. A. & Kuss, A. W. et al. (2016)
Journal of Alzheimer s Disease, 50(2) pp. 397-409. DOI: https://doi.org/10.3233/JAD-150745
Details DOI PMID PMC WoS
-
2016 | Journal Article
N-Truncated A beta(2-X) Starting with Position Two in Sporadic Alzheimer's Disease Cases and Two Alzheimer Mouse Models
Savastano, A.; Klafki, H.; Haussman, U.; Oberstein, T. J.; Mueller, P.; Wirths, O. & Wiltfang, J. et al. (2016)
Journal of Alzheimer s Disease, 49(1) pp. 101-110. DOI: https://doi.org/10.3233/JAD-150394
Details DOI PMID PMC WoS
-
2015 | Journal Article
I716F AβPP Mutation Associates with the Deposition of Oligomeric Pyroglutamate Amyloid-β and α-Synucleinopathy with Lewy Bodies
Sieczkowski, E.; Milenkovic, I.; Venkataramani, V.; Giera, R.; Ströbel, T.; Höftberger, R. & Liberski, P. P. et al. (2015)
Journal of Alzheimer's Disease, 44(1) pp. 103-114. DOI: https://doi.org/10.3233/JAD-141524
Details DOI
-
2015 | Journal Article
Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease
Richard, B. C. ; Kurdakova, A.; Baches, S.; Bayer, T. A.; Weggen, S. & Wirths, O. (2015)
Journal of Alzheimer s Disease, 45(4) pp. 1223-1236. DOI: https://doi.org/10.3233/JAD-143120
Details DOI PMID PMC WoS
-
2014 | Journal Article |
Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer's disease by deep sequencing
Bouter, Y.; Kacprowski, T.; Weissmann, R.; Dietrich, K.; Borgers, H.; Brauss, A. & Sperling, C. et al. (2014)
Frontiers in Aging Neuroscience, 6. DOI: https://doi.org/10.3389/fnagi.2014.00075
Details DOI WoS
-
2014 | Review |
Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease
Bayer, T. A.& Wirths, O. (2014)
Acta Neuropathologica, 127(6) pp. 787-801.
Springer. DOI: https://doi.org/10.1007/s00401-014-1287-x
Details DOI PMID PMC WoS
-
2014 | Journal Article
A beta(38) in the Brains of Patients with Sporadic and Familial Alzheimer's Disease and Transgenic Mouse Models
Reinert, J.; Martens, H.; Huettenrauch, M.; Kolbow, T.; Lannfelt, L.; Ingelsson, M. & Paetau, A. et al. (2014)
Journal of Alzheimer s Disease, 39(4) pp. 871-881. DOI: https://doi.org/10.3233/JAD-131373
Details DOI PMID PMC WoS
-
2014 | Journal Article |
Axonal degeneration in an Alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal A beta accumulation
Christensen, D. Z.; Huettenrauch, M. ; Mitkovski, M.; Pradier, L. & Wirths, O. (2014)
Frontiers in Aging Neuroscience, 6 art. 139. DOI: https://doi.org/10.3389/fnagi.2014.00139
Details DOI PMID PMC WoS